Selection of Patients
Patients Studied by Echocardiography Echocardiograms were obtained in 119 patients evaluated for coronary artery disease at the National Heart, Lung, and Blood Institute (NHLBI) from [1973] [1974] [1975] . Forty patients (28%) had echocardiograms that were unsatisfactory for precise measurement of ventricular wall thicknesses and were excluded from the study. The remaining 79 patients with satisfactory echocardiograms comprise the study group. Patients ranged from 23 to 65 years (median 52). Sixty-seven patients were men and 12 were women. All study patients had been admitted to the NHLBI for diagnostic evaluation either because of a history of chest pain or because of a previous diagnosis of coronary artery disease. In 77 of the 79 patients the diagnosis of hypertrophic cardiomyopathy (i.e., ASH) was neither made nor suspected by the referring physician. The two remaining used for interpretation. The time between cardiac catheterization and recording of the echocardiogram was less than one year (median 4 days) and none of these patients experienced a clinically evident myocardial infarction or other serious cardiac disorder during this interval. In the remaining 12 patients, all of whom underwent aortocoronary bypass graft operations, a postoperative echocardiogram was used for interpretation. The electrocardiographic evidence of perioperative myocardial infarction (i.e., the development of Q waves postoperatively) was definite in one patient and equivocal in two other patients. None of these three patients had disproportionate septal thickening by echocardiography.
Echocardiograms were also performed in 42 first degree relatives (offspring and siblings, but no parental pairs) of all seven of the patients with echocardiographically determined disproportionate septal thickening and two of the 10 patients with disproportionate septal thickening identified at necropsy. Ages ranged from 12 to 72 years (median 33). The number of subjects studied in each family ranged from two to nine (median five). 1856 Visicorder and recorded continuously on light sensitive paper. Thickness of the ventricular septum was measured below the tips of the mitral valve leaflets just prior to atrial systole; posterobasal* left ventricular wall thickness was measured at the level of the tips of the mitral valve leaflets during the same phase of the cardiac cycle.
Gross Pathology
Measurements of ventricular wall thicknesses were made in the following areas: 1) ventricular septum, about onethird the distance between the aortic valve and left ventricular apex; 2) posterobasal left ventricular free wall, directly behind the mid-point of the posterior mitral valve leaflet and at the level of the tips of the mitral leaflets; and 3) right ventricular wall in the area of maximum thickness. Care was taken to avoid including trabeculae, papillary muscles or crista supraventricularis in the measurement of wall thickness.
Histology
Blocks of myocardium were taken from the full thickness of 1) ventricular septum about one-third the distance between the aortic valve and left ventricular apex; 2) anterolateral left ventricular free wall about 2 cm lateral to the anterior descending coronary artery; and 3) posterior left ventricular wall about one-half the distance between the mitral valve anulus and left ventricular apex. All tissue specimens were embedded in paraffin, sectioned at a thickness of 6,g and stained with hematoxylin and eosin. The extent of disorganization of cardiac muscle cells was graded in each tissue block.8 14 Marked fibrosis was present in many blocks of tissue; analysis of cellular arrangement was limited to those areas of myocardium relatively free of fibrosis. Areas immediately adjacent to marked scarring also were not analyzed.
Results

Echocardiographic Findings
Ventricular septal and posterobasal left ventricular free wall thicknesses and septal-free wall ratios in each of the 79 patients studied by echocardiography are shown in figure 1. Mean ventricular septal thickness was 13.2 ± 0.3 (SEM) mm, mean posterobasal left ventricular wall thickness was 12.5 ± 0.2 mm and mean septal-free wall thickness ratio was 1.05 ± 0.01. In seven (9%) of the 79 patients the septalfree wall ratio was 1.3 or greater and, therefore, met our criteria for disproportionate ventricular septal thickening2' 3, 15 (table 2) . Septal-free wall ratios in four of these patients were 1.4 and in the other three patients were 1.5 or greater. Three of the 79 patients in this study group (each with disproportionate septal thickening) showed systolic anterior motion of the anterior mitral leaflet.
Necropsy Findings
Gross Pathology
In the 72 patients studied at necropsy, heart weights ranged from 240 to 830 grams and all were increased com-*The term posterobasal left ventricular wall is used to describe that region of the left ventricular free wall which is visualized by echocardiography; it lies directly behind the posterior mitral leaflet at the level of the tips of the mitral leaflets. This area often is described by pathologists as the lateral or posterolateral left ventricular free wall. (table 2) . Septal-free wall ratios in five of these 10 patients were 1.3 or 1.4, and in the other five patients were 1.5 or greater. There was no relation between right ventricular wall thickness and ventricular septal thickness or septal-free wall ratio in patients studied at necropsy. In figure 3 , the frequency distribution of septalfree wall ratios for the group of 79 patients with coronary artery disease studied by echocardiography is compared to that of 72 patients studied at necropsy. The similarity between these two distribution curves is evident. In three of the ten patients with disproportionate septal thickening studied at necropsy, marked scar formation associated with loss of muscle was present in the area of left ventricular free wall through which the ultrasound beam presumably would pass during life. Specifically, this area of the left ventricle is the posterobasal wall behind the midpoint of the posterior mitral leaflet, at the level of the tips of the mitral leaflets ( fig. 4 ). In these patients ventricular septal thicknesses were moderately increased (i.e., 20 mm, 20 mm and 16 mm), and the posterobasal left ventricular wall of each patient (i.e., 10 mm, 10 mm and 7 mm in thickness, respectively) was thinner than surrounding myocardium uninvolved by scar. The myocardium surrounding the scar in each of these patients was 17 mm, 13 mm and 12 mm in thickness, respectively. Hence, when the unscarred portion of posterobasal left ventricular wall was used in the calculation of septal-free wall ratio one of the three patients actually did not satisfy our criteria for disproportionate septal thickening (septal-free wall ratio of . 1.3) and one other patient had a borderline ratio of 1.3.
In the patients studied at necropsy or by echocardiography there was no correlation between the occurrence of disproportionate septal thickening and the following clinical parameters: age and sex of the patient, severity and distribution of coronary artery lesions ( 
Analysis of Family Members
All 28 first degree relatives of six index cases with coronary artery disease and disproportionate septal thickening showed normal septal-free wall ratios (i.e., < 1.3) by echocardiography. However, relatively few first degree relatives of three of these patients were studied making any definitive conclusions regarding the lack of genetic transmission of disproportionate septal thickening uncertain in those families. In the remaining three families, with a total of 14 first degree relatives studied by echocardiography, one, two or three relatives showed disproportionate septal thickening (septal-free wall ratios ranged from 1.4 to 2.0). These data are summarized in table 2.
Discussion
The results of this study indicate that about 10% of the patients with coronary artery disease we studied by echocardiography or at necropsy demonstrated abnormal septalfree wall thickness ratios (i.e., > 1.3). Our data also indicate that the disproportionate septal thickening in such patients may have three possible etiologies.
First, in some patients coronary artery disease may coexist with genetically transmitted hypertrophic cardiomyopathy. Such patients have been identified by previous investigators as having idiopathic hypertrophic subaortic stenosis.i0 13 This association is not unexpected because of the relatively high frequency with which coronary artery disease occurs in the population. In this study we found definitive evidence (by echocardiography) of genetic transmission of ASH in the families of three of seven patients with coronary artery disease and echocardiographically determined disproportionate septal thickening.
Second, it appears that in other patients with coronary artery disease and associated disproportionate septal thickening, the latter is not genetically transmitted as a separate etiologically distinct entity. In this regard, we found by echocardiography no evidence of genetic transmission of ASH in first degree relatives of one patient with coronary artery disease and echocardiographically determined disproportionate septal thickening who had five first degree relatives studied. In addition, disproportionate septal thickening was absent in three other families in which only two or three relatives were studied. However, because the number of relatives studied in these families was relatively small, it is still possible that the disproportionate septal thickening in the index case was a manifestation of genetically transmitted hypertrophic cardiomyopathy. We accept negative echocardiographic studies in five first degree adult relatives (other than parents) as a minimum to conclude that genetic transmission of ASH is unlikely. This is because the probability that five relatives of a patient with genetically transmitted hypertrophic cardiomyopathy will each have negative echocardiographic studies due to chance alone is only about 3% (assuming that each adult member of such a family has a. 50% chance of being affected). Furthermore, none of the ten patients with disproportionate septal thickening studied at necropsy had evidence of genetically transmitted hypertrophic cardiomyopathy. This conclusion is based on negative echocardiographic studies in first degree relatives of two patients and absence of numerous disorganized cardiac muscle cells in the ventricular septum of all ten patients. Numerous disorganized cardiac muscle cells are rarely present in the ventricular septum of patients with disproportionate septal thickening and associated acquired or congenital heart diseases.9 Moreover, these cells are rarely absent in the ventricular septum of patients with genetically transmitted hypertrophic cardiomyopathy. '4, 17, 18 Hence, in some patients with coronary artery disease, disproportionate septal thickening may occur as a secondary phenomenon and not be a manifestation of hypertrophic cardiomyopathy. The mechanism by which disproportionate septal thickening develops in patients with coronary artery disease is unclear. However, it is possible that in some patients the ventricular septum thickens as a compensatory mechanism for diminished contraction in another area of the heart which has undergone ischemic injury. It is also possible that some patients may have developed disproportionate septal thickening secondary to the fortuitous association of coronary artery disease and disproportionate septal thickening in an individual who is simply at the extreme end of the normal distribution curve for septal thickness. Finally, disproportionate septal thickening could be due to coexistent systemic hypertension although such a finding is not common in patients with systemic hypertension and no coronary artery disease. '9 Although 9% of our patients studied by echocardiography had abnormal septal-free wall ratios, if the three patients with genetically transmitted hypertrophic cardiomyopathy are excluded, the prevalence of secondary disproportionate septal thickening is only 5%. Moreover, since relatively few first degree relatives of three other patients with coronary artery disease and disproportionate septal thickening were available for echocardiographic study, it is possible that the actual prevalence of secondary disproportionate thickening in this group of patients may even be lower.
Necropsy findings in a small number of our patients suggest a third factor that may contribute to an abnormal septal-free wall ratio in patients with coronary artery disease, i.e., scarring and loss of muscle in the posterobasal left ventricular wall. Three of the ten patients studied at necropsy with an abnormally increased septal-free wall ratio showed thinning of the left ventricular wall in the area through which the ultrasound beam would presumably have passed during life. One of these three patients would not have had disproportionate septal thickening if the myocardium surrounding the scar had been used to calculate septalfree wall ratio. The remaining two patients would have had disproportionate septal thickening regardless of whether the thickness of the scarred or unscarred areas of the posterobasal wall had been used to obtain the septal-free wall ratio, primarily because of excessive ventricular septal thickening. None of the patients with posterobasal wall scarring observed at necropsy had echocardiographic studies during life. Hence, it is possible that because the ultrasound beam has a finite width, detection of scars the size of those present at necropsy in our three patients would not four patients. The echocardiographic features in patients with SAM alone, ASH and SAM, and ASH alone were compared. LVOT measurements in patients with SAM alone (2.2 ± .4 cm) and ASH and SAM (2.1 ± .5 cm) were similar and narrower than in patients with ASH alone (2.8 ± .5 cm, P < 0.001). Ejection fractions in patients with SAM alone (79 ± 10%) were greater than in patients with ASH and SAM (66 ± 16%, P < 0.02) or ASH alone (60 ± 15%, P < 0.001). Thus, dynamic left ventricular outflow obstruction can exist in the absence of echocardiographic ASH. LVOT width and abnormal LV ejection dynamics may contribute to the LVOT obstruction with or without the presence of ASH.
recently been reported in patients without detectable cardiovascular disease.7' 8 However, the hemodynamic significance of SAM without ASH is unknown. The purpose of this report is to describe the clinical, echocardiographic, and hemodynamic features in 10 of our patients with SAM who had normal septal thickness.
Materials and Methods
The clinical, echocardiographic, and hemodynamic data on all patients with SAM or ASH or both, documented at our institution, were reviewed. Clinical data based on symptoms, physical findings, and electrocardiographic abnormalities were analyzed.
We performed echocardiographic studies with the patients in the supine or left lateral decubitus position, utilizing a Smith Kline Ekoline 20A ultrasonoscope with a 2.25 MHz medium internally focused transducer. Permanent records were obtained with an Irex 101 Continutrace recorder.
The entire septum, from the aortic root to below the tips of the mitral valve, was scanned in all patients to detect septal hypertrophy. Interventricular septal (IVS) thickness in diastole and systole, percentage of septal thickening, and
